Forte Biosciences (FBRX) Stock Analysis

What Forte Biosciences does

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

Key metrics

ETFs linked to FBRX

Broad-market and Healthcare sector ETFs an investor holding Forte Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how FBRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Forte Biosciences?

Forte Biosciences trades under the ticker FBRX on NASDAQ.

Which exchange is FBRX listed on?

FBRX is listed on NASDAQ.

What sector does Forte Biosciences operate in?

Forte Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze FBRX in a portfolio?

PortView shows FBRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.